Drug reference
Reduction in duration of neutropenia and incidence of febrile neutropenia in cytotoxic chemotherapy for malignancy (except chronic myeloid leukaemia and myelodysplastic syndromes) (specialist use only) ▶BY SUBCUTANEOUS INJECTION ▶Adult: 6 mg for each chemotherapy cycle, to be given at least 24 hours after chemotherapy, dose is expressed as filgrastim
PDF page 1113
Acute leukaemia. myelosuppressive chemotherapy
PDF page 1113
▶Common or very common Myalgia. nausea ▶Uncommon Glomerulonephritis
PDF page 1113
There can be variation in the licensing of different medicines containing the same drug. Solution for injection ▶Neulasta (Amgen Ltd) Filgrastim (as Pegfilgrastim) 10 mg per 1 ml Neulasta 6mg/0.6ml solution for injection pre-filled syringes | 1 pre-filled disposable injection P £686.38 Neulasta 6mg/0.6ml solution for injection pre-filled syringes with Onpro kit | 1 pre-filled disposable injection P £686.38 (Hospital only) ▶Pelgraz (Accord Healthcare Ltd) A Filgrastim (as Pegfilgrastim) 10 mg per 1 ml Pelgraz 6mg/0.6ml solution for injection pre-filled syringes | 1 pre-filled disposable injection P £686.37 (Hospital only) ▶Pelmeg (Napp Pharmaceuticals Ltd) A Filgrastim (as Pegfilgrastim) 10 mg per 1 ml Pelmeg 6mg/0.6ml solution for injection pre-filled syringes | 1 pre-filled disposable injection P £411.83 (Hospital only) ▶Ziextenzo (Sandoz Ltd) A Filgrastim (as Pegfilgrastim) 10 mg per 1 ml Ziextenzo 6mg/0.6ml solution for injection pre-filled syringes | 1 pre-filled disposable injection P £617.74 3.2 Stem cell mobilisation IMMUNOSTIMULANTS › CHEMOKINE RECEPTOR ANTAGONISTS
PDF page 1113
6 mg for each chemotherapy cycle, to be given at
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1113
